Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practice.

ABSTRACT:

Background

Since HIV+ treatment has become more effective, the average age of people living with HIV (PLWHIV) has increased, and consequently the incidence of developing comorbidities, making the clinical and economic management of HIV+ patients more complex. Limited literature exists regarding the management of comorbidities costs. This study is aimed at defining and comparing the total annual costs of comorbidities, in an Italian cohort of HIV and HIV/HCV patients, from the National Healthcare Service perspective. The authors hypothesised that there are higher costs, for patients with multiple comorbidities, and a greater consumption of resources for HIV/HCV co-infected patients versus HIV mono-infected patients.

Methods

An observational retrospective multi-centre health-e

SUBMITTER: Garagiola E 

PROVIDER: S-EPMC7456501 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature